Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 38% ± 7% | |
glutamatergic neuron | 3 studies | 43% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 30% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 1132.95 | 456 / 459 | 85% | 8.07 | 952 / 1118 |
pancreas | 100% | 5300.02 | 328 / 328 | 81% | 5.85 | 144 / 178 |
lung | 97% | 1111.41 | 563 / 578 | 78% | 5.98 | 905 / 1155 |
brain | 82% | 685.59 | 2177 / 2642 | 93% | 8.39 | 658 / 705 |
stomach | 99% | 1215.04 | 356 / 359 | 65% | 4.04 | 185 / 286 |
esophagus | 76% | 667.42 | 1102 / 1445 | 79% | 7.85 | 144 / 183 |
skin | 83% | 4963.60 | 1498 / 1809 | 67% | 6.74 | 314 / 472 |
bladder | 100% | 1023.19 | 21 / 21 | 44% | 2.66 | 223 / 504 |
intestine | 92% | 771.10 | 888 / 966 | 49% | 2.92 | 259 / 527 |
uterus | 94% | 878.84 | 160 / 170 | 39% | 2.86 | 179 / 459 |
thymus | 97% | 826.95 | 631 / 653 | 20% | 0.73 | 119 / 605 |
prostate | 91% | 785.20 | 224 / 245 | 21% | 0.72 | 105 / 502 |
blood vessel | 100% | 1894.57 | 1332 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 1585.57 | 1201 / 1204 | 0% | 0 | 0 / 0 |
ovary | 30% | 194.99 | 54 / 180 | 60% | 3.10 | 260 / 430 |
adrenal gland | 55% | 245.46 | 142 / 258 | 35% | 1.75 | 80 / 230 |
eye | 0% | 0 | 0 / 0 | 81% | 10.40 | 65 / 80 |
heart | 75% | 557.67 | 646 / 861 | 0% | 0 | 0 / 0 |
spleen | 68% | 333.99 | 163 / 241 | 0% | 0 | 0 / 0 |
kidney | 24% | 98.46 | 21 / 89 | 30% | 1.55 | 270 / 901 |
tonsil | 0% | 0 | 0 / 0 | 42% | 2.21 | 19 / 45 |
muscle | 25% | 100.86 | 199 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 18% | 488.58 | 170 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.41 | 4 / 29 |
liver | 2% | 7.00 | 4 / 226 | 4% | 0.14 | 17 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046655 | Biological process | folic acid metabolic process |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0006730 | Biological process | one-carbon metabolic process |
GO_0006740 | Biological process | NADPH regeneration |
GO_0009058 | Biological process | biosynthetic process |
GO_0009258 | Biological process | 10-formyltetrahydrofolate catabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0016155 | Molecular function | formyltetrahydrofolate dehydrogenase activity |
GO_0004029 | Molecular function | aldehyde dehydrogenase (NAD+) activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ALDH1L2 |
Protein name | 10-formyltetrahydrofolate dehydrogenase (EC 1.5.1.6) Aldehyde dehydrogenase 1 family member L2 Mitochondrial 10-formyltetrahydrofolate dehydrogenase (Mitochondrial 10-FTHFDH) (mtFDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L2) |
Synonyms | |
Description | FUNCTION: Mitochondrial 10-formyltetrahydrofolate dehydrogenase that catalyzes the NADP(+)-dependent conversion of 10-formyltetrahydrofolate to tetrahydrofolate and carbon dioxide. . |
Accessions | A0A494C1M4 Q3SY69 ENST00000652515.1 ENST00000552270.1 [Q3SY69-2] ENST00000548418.1 ENST00000258494.14 [Q3SY69-1] H0YHN9 |